Characterization of periostin isoform pattern in non-small cell lung cancer

Lung Cancer

Volumn 76, Issue 2, 2012, Pages 183-190

  Morra, Laura ^a   Rechsteiner, Markus ^a   Casagrande, Silvia ^a   Von Teichman, Adriana ^a   Schraml, Peter ^a   Moch, Holger ^a   Soltermann, Alex ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Epithelial mesenchymal transition; Isoforms; Laser capture microdissection; Non small cell lung cancer; Periostin protein; Tissue microarray analysis

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; FORMALDEHYDE; ISOPROTEIN; MESSENGER RNA; RNA; TRANSCRIPTION FACTOR RUNX2; VIMENTIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; STROMA; TUMOR VOLUME; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; COHORT STUDIES; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LUNG; LUNG NEOPLASMS; MIDDLE AGED; PROTEIN ISOFORMS; RNA, MESSENGER; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84859425412     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.10.013     Document Type: Article

References (39)

1. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
2. Yilmaz M., Christofori G., Lehembre F. Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med 2007, 13:535-541.
3. Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011, 6:244-285.
4. Sakurai H., Maeshima A., Watanabe S., Suzuki K., Tsuchiya R., Maeshima A.M., et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol 2004, 28:198-206.
5. Soltermann A., Tischler V., Arbogast S., Braun J., Probst-Hensch N., Weder W., et al. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 2008, 14:7430-7437.
6. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009, 9:265-273.
7. Takeshita S., Kikuno R., Tezuka K., Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 1993, 294(Pt 1):271-278.
8. Horiuchi K., Amizuka N., Takeshita S., Takamatsu H., Katsuura M., Ozawa H., et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999, 14:1239-1249.
9. Inai K., Norris R.A., Hoffman S., Markwald R.R., Sugi Y. BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis. Dev Biol 2008, 315:383-396.
10. Kruzynska-Frejtag A., Machnicki M., Rogers R., Markwald R.R., Conway S.J. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 2001, 103:183-188.
11. Kruzynska-Frejtag A., Wang J., Maeda M., Rogers R., Krug E., Hoffman S., et al. Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction. Dev Dyn 2004, 229:857-868.
12. Wilde J., Yokozeki M., Terai K., Kudo A., Moriyama K. The divergent expression of periostin mRNA in the periodontal ligament during experimental tooth movement. Cell Tissue Res 2003, 312:345-351.
13. Nakazawa T., Nakajima A., Seki N., Okawa A., Kato M., Moriya H., et al. Gene expression of periostin in the early stage of fracture healing detected by cDNA microarray analysis. J Orthop Res 2004, 22:520-525.
14. Lindner V., Wang Q., Conley B.A., Friesel R.E., Vary C.P. Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol 2005, 25:77-83.
15. Shimazaki M., Kudo A. Periostin, acting in regeneration of periodontal ligament, contributes to cardiac healing and tumor capsule formation. Fukuoka Igaku Zasshi 2009, 100:67-74.
16. Erkan M., Kleeff J., Gorbachevski A., Reiser C., Mitkus T., Esposito I., et al. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 2007, 132:1447-1464.
17. Gillan L., Matei D., Fishman D.A., Gerbin C.S., Karlan B.Y., Chang D.D. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res 2002, 62:5358-5364.
18. Shao R., Bao S., Bai X., Blanchette C., Anderson R.M., Dang T., et al. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 2004, 24:3992-4003.
19. Bao S., Ouyang G., Bai X., Huang Z., Ma C., Liu M., et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 2004, 5:329-339.
20. Kudo Y., Ogawa I., Kitajima S., Kitagawa M., Kawai H., Gaffney P.M., et al. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 2006, 66:6928-6935.
21. Sasaki H., Sato Y., Kondo S., Fukai I., Kiriyama M., Yamakawa Y., et al. Expression of the periostin mRNA level in neuroblastoma. J Pediatr Surg 2002, 37:1293-1297.
22. Yan W., Shao R. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem 2006, 281:19700-19708.
23. Kim C.J., Sakamoto K., Tambe Y., Inoue H. Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells. Int J Oncol 2011, 38:1759-1766.
24. Baril P., Gangeswaran R., Mahon P.C., Caulee K., Kocher H.M., Harada T., et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene 2007, 26:2082-2094.
25. Li P., Oparil S., Feng W., Chen Y.F. Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. J Appl Physiol 2004, 97:1550-1558. discussion 1549.
26. Castronovo V., Waltregny D., Kischel P., Roesli C., Elia G., Rybak J.N., et al. A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer. Mol Cell Proteomics 2006, 5:2083-2091.
27. Kudo Y., Siriwardena B.S., Hatano H., Ogawa I., Takata T. Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol 2007, 22:1167-1174.
28. Litvin J., Selim A.H., Montgomery M.O., Lehmann K., Rico M.C., Devlin H., et al. Expression and function of periostin-isoforms in bone. J Cell Biochem 2004, 92:1044-1061.
29. Kim C.J., Isono T., Tambe Y., Chano T., Okabe H., Okada Y., et al. Role of alternative splicing of periostin in human bladder carcinogenesis. Int J Oncol 2008, 32:161-169.
30. Soltermann A., Ossola R., Kilgus-Hawelski S., von Eckardstein A., Suter T., Aebersold R., et al. N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics. Cancer 2008, 114:124-133.
31. Morra L., Rechsteiner M., Casagrande S., Duc Luu V., Santimaria R., Diener P.A., et al. Relevance of periostin splice variants in renal cell carcinoma. Am J Pathol 2011, 179:1513-1521.
32. Schramm A., Opitz I., Thies S., Seifert B., Moch H., Weder W., et al. Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma. Eur J Cardiothorac Surg 2010, 37:566-572.
33. Riener M.O., Fritzsche F.R., Soll C., Pestalozzi B.C., Probst-Hensch N., Clavien P.A., et al. Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology 2010, 56:600-606.
34. Tischler V., Fritzsche F.R., Wild P.J., Stephan C., Seifert H.H., Riener M.O., et al. Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer 2010, 10:273.
35. Dahinden C., Ingold B., Wild P., Boysen G., Luu V.D., Montani M., et al. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res 2010, 16:88-98.
36. Fisseler-Eckhoff A. New TNM classification of malignant lung tumors 2009 from a pathology perspective. Pathologe 2009, 30(Suppl. 2):193-199.
37. Liu D.W., Chen S.T., Liu H.P. Choice of endogenous control for gene expression in nonsmall cell lung cancer. Eur Respir J 2005, 26:1002-1008.
38. Tilman G., Mattiussi M., Brasseur F., van Baren N., Decottignies A. Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol Cancer 2007, 6:80.
39. Hong L., Sun H., Lv X., Yang D., Zhang J., Shi Y. Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro. Mol Biol Rep 2010, 37:2285-2293.